Treatment of HSV Flare-Up on Nose with Lymphadenopathy and Facial Paresthesia
Start oral valacyclovir 1 gram three times daily for 7-10 days immediately, as this presentation suggests a severe or first-episode HSV infection with potential neurological involvement requiring aggressive systemic therapy. 1, 2
Immediate Treatment Approach
Systemic Antiviral Therapy (First-Line)
Initiate high-dose oral antiviral therapy immediately without waiting for laboratory confirmation, as early treatment (within 48-72 hours) is critical for optimal outcomes 1, 2
Preferred regimen: Valacyclovir 1 gram orally three times daily for 7-10 days 1
Alternative regimens if valacyclovir is unavailable:
Why High-Dose Therapy is Critical Here
The presence of lymphadenopathy and facial paresthesia suggests this is either a severe first episode or extensive reactivation with potential trigeminal nerve involvement 4, 5. The facial paresthesia indicates viral activity along the trigeminal nerve distribution, which supplies sensation to the nose and face 4. This warrants more aggressive dosing than typical recurrent herpes labialis 6, 1.
Topical Therapy Considerations
Avoid topical antivirals as monotherapy for this presentation, as they are substantially less effective than oral therapy and inadequate for systemic involvement 7, 8
Topical ganciclovir 0.15% gel may be added as adjunctive therapy if there is ocular involvement or concern for periocular spread, applied 3-5 times daily 9, 3
Critical warning: Never use topical corticosteroids, as they potentiate HSV infection and can lead to dissemination 9, 3
Assessment for Complications
Evaluate for Disseminated or Severe Disease
Assess immune status immediately: The combination of facial HSV with lymphadenopathy raises concern for immunocompromise 10, 11
Red flags requiring hospitalization and IV therapy:
If severe or immunocompromised: Switch to IV acyclovir 5-10 mg/kg every 8 hours 10, 11
Rule Out Varicella Zoster Virus
The facial paresthesia and lymphadenopathy could also represent herpes zoster (shingles) rather than HSV 3. If vesicles follow a dermatomal distribution or if there is severe pain, consider:
- Valacyclovir 1 gram three times daily for 7 days for herpes zoster 2
- This dosing is appropriate for both HSV and VZV, providing coverage while awaiting diagnostic confirmation 3, 11
Diagnostic Confirmation
Obtain viral culture or PCR from vesicular fluid if lesions are present to confirm HSV versus VZV and establish baseline for potential resistance 10, 11
Consider HIV testing in any patient with severe or atypical HSV presentation 11
Follow-Up and Monitoring
Reassess within 5-7 days to ensure clinical improvement 10
If no response by day 5-7, suspect acyclovir resistance and consider:
Monitor for ocular involvement given the nasal location, as HSV can spread to the eye causing keratitis 9, 3
Common Pitfalls to Avoid
Do not use short-course therapy (1-5 days) for this presentation, as it is designed only for simple recurrent herpes labialis without systemic features 6, 2
Do not delay treatment waiting for laboratory confirmation, as efficacy decreases significantly after 72 hours 1, 2
Do not assume this is simple herpes labialis - the lymphadenopathy and paresthesia indicate more extensive disease requiring longer treatment duration 4, 5
Avoid topical acyclovir entirely as it has substantially lower effectiveness compared to oral therapy 7, 8